MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins

FEBS Letters

Volumn 589, Issue 2, 2015, Pages 207-214

  Gao, Yongtao ^a   Liu, Te ^a,b,c   Huang, Yongyi ^d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d UNIVERSITÉ DE TOULON   (France)

Author keywords

DLK1 DIO3 genomic imprinted microRNA cluster; Human endometrial cancer stem cell; MicroRNA 134; Migration; Notch pathway; Proliferation; Protein O glucosyltransferase 1

Indexed keywords

MEMBRANE PROTEIN; MICRORNA; MICRORNA 134; NOTCH RECEPTOR; PROTEIN O GLUCOSYLTRANSFERASE 1; UNCLASSIFIED DRUG; GLUCOSYLTRANSFERASE; MIRN134 MICRORNA, HUMAN; POGLUT1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOMETRIAL CANCER CELL LINE; ENDOMETRIUM CANCER; FLUORESCENCE ACTIVATED CELL SORTING; G2 PHASE CELL CYCLE CHECKPOINT; GENE AMPLIFICATION; GENE OVEREXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; CELL LINE; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

CELL LINE; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSYLTRANSFERASES; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84920726953     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.12.002     Document Type: Article

References (30)

1. P.A. Gehrig, and V.L. Bae-Jump Promising novel therapies for the treatment of endometrial cancer Gynecol. Oncol. 116 2009 187 194
2. F. Jiang, T. Liu, Y. He, Q. Yan, X. Chen, H. Wang, and X. Wan MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo BMC Cancer 11 2011 425
3. Q. Zhang, J. Celestino, R. Schmandt, A.S. McCampbell, D.L. Urbauer, L.A. Meyer, J.K. Burzawa, M. Huang, M.S. Yates, D. Iglesias, R.R. Broaddus, and K.H. Lu Chemopreventive effects of metformin on obesity-associated endometrial proliferation Am. J. Obstet. Gynecol. 209 2013 24 e1-24 e12
4. Y. Gao, T. Liu, W. Cheng, and H. Wang Isolation and characterization of proliferative, migratory and multidrug-resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines Oncol. Rep. 28 2012 527 532
5. J.M. Bouyssou, S. Manier, D. Huynh, S. Issa, A.M. Roccaro, and I.M. Ghobrial Regulation of microRNAs in cancer metastasis Biochim. Biophys. Acta 2014
6. R.G. Lerner, and C. Petritsch A microRNA-operated switch of asymmetric-to-symmetric cancer stem cell divisions Nat. Cell Biol. 16 2014 212 214
7. D. Sayed, and M. Abdellatif MicroRNAs in development and disease Physiol. Rev. 91 2011 827 887
8. L. Zhang, T. Liu, Y. Huang, and J. Liu MicroRNA-182 inhibits the proliferation and invasion of human lung adenocarcinoma cells through its effect on human cortical actin-associated protein Int. J. Mol. Med. 28 2011 381 388
9. W. Cheng, T. Liu, X. Wan, Y. Gao, and H. Wang MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells FEBS J. 279 2012 2047 2059
10. W. Qin, Q. Ren, T. Liu, Y. Huang, and J. Wang MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1 FEBS Lett. 587 2013 1434 1439
11. Y. Peng, Y. Dai, C. Hitchcock, X. Yang, E.S. Kassis, L. Liu, Z. Luo, H.L. Sun, R. Cui, H. Wei, T. Kim, T.J. Lee, Y.J. Jeon, G.J. Nuovo, S. Volinia, Q. He, J. Yu, P. Nana-Sinkam, and C.M. Croce Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer Proc. Natl. Acad. Sci. U.S.A. 110 2013 15043 15048
12. P. Dong, M. Kaneuchi, Y. Konno, H. Watari, S. Sudo, and N. Sakuragi Emerging therapeutic biomarkers in endometrial cancer Biomed. Res. Int. 2013 2013 130362
13. P. Dong, Y. Konno, H. Watari, M. Hosaka, M. Noguchi, and N. Sakuragi The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer J. Transl. Med. 12 2014 231
14. L. Benetatos, E. Hatzimichael, E. Londin, G. Vartholomatos, P. Loher, I. Rigoutsos, and E. Briasoulis The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis Cell. Mol. Life Sci. 70 2012 795 814
15. S.P. Lin, P. Coan, S.T. da Rocha, H. Seitz, J. Cavaille, P.W. Teng, S. Takada, and A.C. Ferguson-Smith Differential regulation of imprinting in the murine embryo and placenta by the Dlk1-Dio3 imprinting control region Development 134 2007 417 426
16. J.M. Luk, J. Burchard, C. Zhang, A.M. Liu, K.F. Wong, F.H. Shek, N.P. Lee, S.T. Fan, R.T. Poon, I. Ivanovska, U. Philippar, M.A. Cleary, C.A. Buser, P.M. Shaw, C.N. Lee, D.G. Tenen, H. Dai, and M. Mao DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival J. Biol. Chem. 286 2011 30706 30713
17. C. Yin, P.Q. Wang, W.P. Xu, Y. Yang, Q. Zhang, B.F. Ning, P.P. Zhang, W.P. Zhou, W.F. Xie, W.S. Chen, and X. Zhang Hepatocyte nuclear factor-4alpha reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region Hepatology 58 2013 1964 1976
18. C.L. Haga, and D.G. Phinney MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network J. Biol. Chem. 287 2012 42695 42707
19. W. Ma, J. Du, Q. Chu, Y. Wang, L. Liu, M. Song, and W. Wang HCLP46 regulates U937 cell proliferation via Notch signaling pathway Biochem. Biophys. Res. Commun. 408 2011 84 88
20. Q. Chu, L. Liu, and W. Wang Overexpression of hCLP46 enhances Notch activation and regulates cell proliferation in a cell type-dependent manner Cell Prolif. 46 2013 254 262
21. G. Jin, Z. Cao, X. Sun, K. Wang, T. Huang, and B. Shen Protein O-glucosyltransferase 1 overexpression downregulates p16 in BT474 human breast cancer cells Oncol. Lett. 8 2014 594 600
22. H. Jafar-Nejad, J. Leonardi, and R. Fernandez-Valdivia Role of glycans and glycosyltransferases in the regulation of Notch signaling Glycobiology 20 2010 931 949
23. M. Acar, H. Jafar-Nejad, H. Takeuchi, A. Rajan, D. Ibrani, N.A. Rana, H. Pan, R.S. Haltiwanger, and H.J. Bellen Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is required for Notch signaling Cell 132 2008 247 258
24. M.E. Fortini Notch signaling: the core pathway and its posttranslational regulation Dev. Cell 16 2009 633 647
25. D.J. Moloney, L.H. Shair, F.M. Lu, J. Xia, R. Locke, K.L. Matta, and R.S. Haltiwanger Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules J. Biol. Chem. 275 2000 9604 9611
26. M. Stahl, K. Uemura, C. Ge, S. Shi, Y. Tashima, and P. Stanley Roles of Pofut1 and O-fucose in mammalian Notch signaling J. Biol. Chem. 283 2008 13638 13651
27. T. Liu, Y. Huang, J. Liu, Y. Zhao, L. Jiang, Q. Huang, W. Cheng, and L. Guo MicroRNA-122 influences the development of sperm abnormalities from human induced pluripotent stem cells by regulating TNP2 expression Stem Cells Dev. 22 2012 1839 1850
28. T. Liu, W. Cheng, Y. Gao, H. Wang, and Z. Liu Microarray analysis of microRNA expression patterns in the semen of infertile men with semen abnormalities Mol. Med. Rep. 6 2012 535 542
29. R. Zha, W. Guo, Z. Zhang, Z. Qiu, Q. Wang, J. Ding, S. Huang, T. Chen, J. Gu, M. Yao, and X. He Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin beta1 in hepatocellular carcinoma PLoS One 9 2014 e87665
30. J. Li, Y. Wang, J. Luo, Z. Fu, J. Ying, Y. Yu, and W. Yu MiR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells FEBS Lett. 586 2012 3761 3765